Literature DB >> 12418218

Trapping covalent intermediates on beta-glycosidases.

Jacqueline Wicki1, David R Rose, Stephen G Withers.   

Abstract

The mechanism-based inactivation and subsequent identification of the nucleophilic residue using mass spectrometry have been successfully applied and used to identify the active-site nucleophile in numerous beta-glycosidases, as illustrated using C. fimi exoglycanase. Evidence for a covalent glycosyl-enzyme intermediate has come from X-ray crystallographic analysis of trapped complexes, the first being that of the trapped fluoroglycosyl-enzyme intermediate of Cex. The crystal structure of the trapped fluorocellobiosyl-enzyme complex for Cex has provided useful insights into catalysis and the roles of specific residues at the active site. In addition, information about the conformation of the natural sugar in the covalently bound state and the interactions at the active site was obtained using a mutant form of Cex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12418218     DOI: 10.1016/s0076-6879(02)54007-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  6 in total

1.  Paenibacillus sp. TS12 glucosylceramidase: kinetic studies of a novel sub-family of family 3 glycosidases and identification of the catalytic residues.

Authors:  Krisztina Paal; Makoto Ito; Stephen G Withers
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

2.  Characterization of noncovalent protein-ligand complexes and associated enzyme intermediates of GlcNAc-6-O-sulfotransferase by electrospray ionization FT-ICR mass spectrometry.

Authors:  Yonghao Yu; Colleen E Kirkup; Na Pi; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

3.  Crystal structure and snapshots along the reaction pathway of a family 51 alpha-L-arabinofuranosidase.

Authors:  Klaus Hövel; Dalia Shallom; Karsten Niefind; Valery Belakhov; Gil Shoham; Timor Baasov; Yuval Shoham; Dietmar Schomburg
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

4.  Distinguishing the differences in β-glycosylceramidase folds, dynamics, and actions informs therapeutic uses.

Authors:  Fredj Ben Bdira; Marta Artola; Herman S Overkleeft; Marcellus Ubbink; Johannes M F G Aerts
Journal:  J Lipid Res       Date:  2018-10-02       Impact factor: 5.922

5.  Use of Fluorinated Functionality in Enzyme Inhibitor Development: Mechanistic and Analytical Advantages.

Authors:  David B Berkowitz; Kannan R Karukurichi; Roberto de la Salud-Bea; David L Nelson; Christopher D McCune
Journal:  J Fluor Chem       Date:  2008-09       Impact factor: 2.050

Review 6.  Plant Glycosides and Glycosidases: A Treasure-Trove for Therapeutics.

Authors:  Kassiani Kytidou; Marta Artola; Herman S Overkleeft; Johannes M F G Aerts
Journal:  Front Plant Sci       Date:  2020-04-07       Impact factor: 5.753

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.